Navigation Links
New Stuttering Therapy Scholarship Makes Treatment More Affordable During Tough Economic Times
Date:11/17/2008

The cost of stuttering treatment has become considerably more affordable during this tightened economic environment thanks to a new stuttering therapy scholarship provided by Hollins Communications Research Institute (HCRI).

Roanoke, VA (PRWEB) November 17, 2008 -- The cost of stuttering treatment has become considerably more affordable during this tightened economic environment thanks to a new stuttering therapy scholarship provided by Hollins Communications Research Institute (HCRI -- www.stuttering.org). Founded in 1972, Roanoke, Virginia based HCRI is a world-leading center for the investigation and treatment of stuttering.

Each individual seeking stuttering treatment at HCRI between January, 2008 and May, 2009 will have access to a $1,550 scholarship (based on need) to help offset the cost of therapy. The standard cost of treatment is $4,500, which is priced to meet the nonprofit Institute's actual costs of research and therapy delivery. Yet, by applying the scholarship funds, participants will have a net cost of $2,950 for participation in HCRI's scientifically based program, which has earned acclaim for treatment innovation and therapy results.

HCRI's stuttering therapy, Hollins Fluency Program: Advanced Speech Reconstruction for StutteringTM, helps people who stutter learn how to replace faulty muscle contractions that cause stuttering with new muscle behaviors that generate fluent speech. Treatment consists of 100 clinical hours over a 12-day period and utilizes the latest behavioral, electronic and computer technologies that significantly improve the learning and retention of fluent speech.

The Institute's data shows that 93% of HCRI clients master fluent speech by the end of the stuttering treatment program. Follow-up studies demonstrate 70% to 75% retain fluent speech when evaluated one and two years post therapy.

This new scholarship is made possible through contributions from past HCRI clients who wanted to help other people who stutter experience the same transformational results that HCRI's stuttering therapy program provided to them, according to HCRI Founder and President Ronald L. Webster, Ph.D.

To apply for the scholarship, persons must first complete an application to attend an upcoming HCRI therapy program. An application and more information is available online at www.stuttering.org or by calling 540-265-5650.

About HCRI:
Hollins Communications Research Institute, founded in 1972 by Ronald L. Webster, Ph.D., is a pioneer in the research and treatment of stuttering. The non-profit institute is unique from other stuttering organizations in that work focuses on developing scientifically derived treatment methods, as well as administering stuttering therapy.

More than 5,600 people from 23 countries have come to HCRI for advanced stuttering therapy. Clients include John Stossel of ABC TV's 20/20 program; Annie Glenn, wife of senator and astronaut John Glenn; Lester Hayes of the Oakland Raiders; and Arthur Blank, co-founder of Home Depot and owner of the Atlanta Falcons.

HCRI is located at 7851 Enon Drive, Roanoke, Virginia, 24019. Contact HCRI at admin @ stuttering.org or 540-265-5650. For more information and to view video speech samples, visit www.stuttering.org.

###

Read the full story at http://www.prweb.com/releases/stuttering-therapy/stuttering-treatment/prweb1623394.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Is stuttering in our DNA?
2. Help for Stutterers on The Doctors TV Show Presented by Power Stuttering Center Founder Mark Power
3. Study helps clarify role of vitamin D in cancer therapy
4. FDA Clears the DPL (Deep Penetrating Light) Therapy System for Over-the-Counter - Home Use
5. New Therapy Could Transform Arthritis Treatment
6. Proton therapy may reduce serious side effect of lung cancer treatment
7. Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients
8. Only Half of MS Patients Respond to Interferon Therapy
9. Game Ready(TM) and ReGear Life Sciences(TM) Bring Innovative New Heat Therapy to Market
10. An ideal therapy for peptic ulcer disease
11. The Neuropathy Associations Scientific Research Grants Focus: Autoimmune and Chemotherapy-Induced Neuropathies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Stuttering Therapy Scholarship Makes Treatment More Affordable During Tough Economic Times
(Date:5/2/2016)... PA (PRWEB) , ... May 02, 2016 , ... As ... Healthsystem Association of Pennsylvania (HAP) issues its full support to allow certified nurse practitioners ... physician supervision after they have worked under such supervision for three years and 3,600 ...
(Date:5/2/2016)... ... 2016 , ... Amica Life Insurance Company has unveiled ... various life stages. , The site launched on April 1, and it has ... to the times when life insurance matters most. , “Through our research, we ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... Dr. Philip ... his patients with same day treatments. In the past, many necessary dental treatments could ... work, along with multiple anesthetic shots and extra chair time. Not only could this ...
(Date:5/2/2016)... ... 2016 , ... Further establishing itself as a leader in natural pet products ... Boxes were selected from over 1,000 entrants as a winner and recipient of the ... chews for dogs are a favorite product among pet-parents worldwide, as each whimsical knobby ...
(Date:5/2/2016)... NEW PORT RICHEY, Fla. (PRWEB) , ... ... ... Pharmacology experts and medical researchers report that many commonly used prescription medications, ... memory loss (1). To mitigate these risks, Novus Medical Detox Center ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016  The blood testing market in ... Kalorama Information and The Freedonia Group in a recent ... testing.  The healthcare research firm said that ... collection stations and in improving testing at the provincial ... Blood Testing Market in China , ...
(Date:4/28/2016)... -- , Net Sales of $1.90 billion represent an ... year period, and an increase of 1.2% on an adjusted ... the first quarter were $0.52 reported, a decrease of 47.5% ... of 29.9% over the prior year period , The ... 2016 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ...
(Date:4/28/2016)... 28, 2016 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery systems, ... PIONEERS 2016 conference, presented by Joseph Gunnar & ... New York . Nadav Kidron , CEO ... Presentation Details:   PIONEERS 2016, ...
Breaking Medicine Technology: